Koers Jerusalem Pharmaceutical Co. Palestine Exchange
Aandelen
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- | - |
Omzet 2021 | 46,23 mln. 0 42,84 mln. | Omzet 2022 | 46,14 mln. 0 42,77 mln. | Marktkapitalisatie | 59,04 mln. 0 54,72 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 6 mln. - 5,56 mln. | Nettowinst (verlies) 2022 | 7 mln. - 6,49 mln. | EV/omzet 2021 | 1,04 x |
Nettoliquiditeiten 2021 | 2,86 mln. 0 2,65 mln. | Nettoliquiditeiten 2022 | 5,6 mln. 0 5,19 mln. | EV/omzet 2022 | 1,16 x |
K/w-verhouding 2021 |
7,72
x | K/w-verhouding 2022 |
8,23
x | Werknemers | - |
Dividendrendement 2021 |
4,24% | Dividendrendement 2022 |
4,57% | Vrij verhandelbaar | 36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-07-13 | |
Mohammed Natour
DFI | Director of Finance/CFO | - | 01-03-20 |
Chief Tech/Sci/R&D Officer | - | 01-01-89 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 89 | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,09% | 43,27 mld. | |
+25,28% | 22,92 mld. | |
+19,22% | 15,43 mld. | |
+13,51% | 12,95 mld. | |
+44,01% | 11,83 mld. | |
-7,79% | 6,91 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+13,02% | 5,55 mld. |